ZEB1 and neoplasm: As such, inhibition of PAK4 reduces expression of Slug and Zeb-1, upregulating expression of VCAM-1 and Claudin-14 in tumor ECs, which eventually enhances T cell adhesion and improves CAR T cell immunotherapy [76].